News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. 10-year Treasury yield nears 5%, pressuring equities and raising corporate borrowing costs.
  • Goldman Sachs turns tactically neutral, citing rising yields and near-term inflation prints as key market risks.
  • Japan's yen jumped ahead of a likely BOJ rate hike, triggering FX volatility and Asian market repositioning.
  • Zelenskiy said U.S. envoys proposed ideas but achieved no breakthrough, maintaining geopolitical uncertainty before planned U.S. talks.
  • Biotech volatility rose: Ionis failed a Phase 3, Biohaven was downgraded, while Roivant and Pharvaris reported positive trial results.
  • India's Nifty closed at a one-month low as FMCG, healthcare and oil & gas stocks weighed on market breadth.

Latest Articles

Mount Logan Capital Inc. Announces Completion of SOFIX’s Asset Acquisition from the Yieldstreet Alternative Income Fund

Mount Logan Capital Inc. Announces Completion of SOFIX’s Asset Acquisition from the Yieldstreet Alternative Income Fund

Mount Logan Capital Inc. has successfully completed the acquisition of approximately $130 million in assets from the Yieldstreet Alternative Income Fund (YS AIF) through its managed Opportunistic Credit Interval Fund (SOFIX). This acquisition nearly doubles SOFIX's net assets, is immediately accretive to Mount Logan’s earnings per share, and is exp…

MSCI: A Five-Year Reset Ends — Time to Ride the Next Growth Cycle

MSCI: A Five-Year Reset Ends — Time to Ride the Next Growth Cycle

After a prolonged period of consolidation and an uneven growth cadence, MSCI shows the ingredients for a renewed growth leg: healthy free cash flow, a $41.5B market cap valuation that already prices in premium recurring revenues, improving technicals, and catalytic tailwinds across indices, analytics and ESG. This trade idea lays out an actionable …

Edible Garden Appoints Tetra Pak Veteran Ernesto Insignares as Senior Project Manager to Support Prairie Hills RTD Facility

Edible Garden Appoints Tetra Pak Veteran Ernesto Insignares as Senior Project Manager to Support Prairie Hills RTD Facility

Edible Garden AG Incorporated announced the hiring of Ernesto Insignares, an experienced Tetra Pak executive, as Senior Project Manager to lead the completion and commissioning of its Prairie Hills facility in Iowa. This site will serve as a major manufacturing hub for ready-to-drink nutritional beverages, enhancing the company’s Farm-to-Formula st…

Citi Sees Little Chance Warsh Speech Will Halt Dollar Decline at Jackson Hole

Citi Sees Little Chance Warsh Speech Will Halt Dollar Decline at Jackson Hole

Citi strategists judge that remarks by Federal Reserve Chair Kevin Warsh at the Jackson Hole symposium are unlikely to reverse the recent dollar sell-off. They say the primary vulnerabilities to a continued dollar slide stem from valuation, market positioning and geopolitical risks rather than a substantive probability of a hawkish shock from Warsh…

Quantum Cyber Appoints Veteran Distribution Executive Dennis Schnur as Head of U.S. Sales as Company Advances Toward Commercialization of Domestic Drone Production

Quantum Cyber Appoints Veteran Distribution Executive Dennis Schnur as Head of U.S. Sales as Company Advances Toward Commercialization of Domestic Drone Production

Quantum Cyber N.V., a Nasdaq-listed autonomous defense technology company, announced the appointment of Dennis Schnur as Head of U.S. Sales to support its commercial expansion in the U.S. following acquisition of a Connecticut manufacturing facility and the assembly of its first mini-interceptor drone. Schnur's extensive distribution experience is …

PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss

PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss

PMGC Holdings Inc. announced a non-binding term sheet with space technology company Orbit2Orbit to conduct a microgravity research study of its biopharmaceutical assets EL-22 and EL-32 targeting muscle loss during spaceflight. The collaboration will leverage Orbit2Orbit's Mice2Space platform and PMGC's manufacturing subsidiary A&B Aerospace to supp…

Swvl Announces $13 Million Strategic Investment Round Priced At-The-Market Under Nasdaq Rules led by the Sawiris Family and Coefficient LP to Anchor Its Next Phase of Growth and U.S. Expansion

Swvl Announces $13 Million Strategic Investment Round Priced At-The-Market Under Nasdaq Rules led by the Sawiris Family and Coefficient LP to Anchor Its Next Phase of Growth and U.S. Expansion

Swvl Holdings Corp announced a $13 million strategic investment round through a private placement led by Coefficient LP, backed by the Sawiris family. The funds will support Swvl's U.S. market expansion, new lending offerings for transport partners, and strengthen its balance sheet as it approaches operating breakeven with strong revenue growth in …

Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA® in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Symposium

Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA® in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Symposium

Zevra Therapeutics announced the presentation of long-term real-world data on its approved drug MIPLYFFA® (arimoclomol) for treating Niemann-Pick Disease Type C (NPC). The data underscore sustained disease stabilization across diverse patient populations up to 8 years, with favorable safety profile and no treatment-related discontinuations. These f…

FuelCell Energy Announces Third Quarter 2026 Results Conference Call on September 2, 2026, at 10:00 A.M. Eastern Time

FuelCell Energy Announces Third Quarter 2026 Results Conference Call on September 2, 2026, at 10:00 A.M. Eastern Time

FuelCell Energy, Inc. announced that it will release its third quarter 2026 financial results before the market opens on September 2, 2026. The company's management will host a conference call at 10:00 a.m. Eastern Time on the same day to discuss the results and provide a business update. The call will be webcast live and available for replay on th…

Buy Melrose (MLSPF): Trade the Short Pressure, Size Risk Appropriately

Buy Melrose (MLSPF): Trade the Short Pressure, Size Risk Appropriately

Melrose Industries (MLSPF) is showing the technical base and extreme short-side positioning that can produce outsized rebounds. Enter at $6.58 with a tight stop and staged targets. This is a high-risk, high-reward swing trade: favorable reward-to-risk driven by potential rapid short-covering, balanced against OTC liquidity and fundamental opacity.

KANZHUN LIMITED Declares Annual Cash Dividend

KANZHUN LIMITED Declares Annual Cash Dividend

KANZHUN LIMITED, a leading Chinese online recruitment platform traded on Nasdaq and Hong Kong exchanges, declared an annual cash dividend of US$0.255 per ordinary share (US$0.510 per ADS), totaling approximately US$230 million. This dividend, supported by surplus cash and combined with over US$300 million in share buybacks this year, signifies the …

United Says Airbus A321XLR Deliveries Will Support 2027 Push into Europe

United Says Airbus A321XLR Deliveries Will Support 2027 Push into Europe

United Airlines expects to receive a sufficient number of Airbus A321XLR aircraft to underpin a planned European expansion in 2027, the carrier said, even as Airbus production and supply-chain issues have created delivery challenges industrywide. The long-range single-aisle jet will be used on five new European routes next year and form part of the…

KANZHUN LIMITED Announces Second Quarter 2026 Financial Results

KANZHUN LIMITED Announces Second Quarter 2026 Financial Results

KANZHUN LIMITED, a leading online recruitment platform in China, announced its Q2 2026 financial results showing a 14.1% revenue increase and 173.1% surge in net income year-over-year. Key operational metrics like paid enterprise customers and average monthly active users also grew significantly. The company enhanced its AI capabilities to improve …

OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations

OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations

OrthoPediatrics Corp. has announced the full commercial launch of its 3P Pediatric Plating Platform Hip System following over 350 successful implantations during a limited launch phase. The system provides advanced plating solutions for pediatric orthopedic trauma and deformity corrections and is the first in a series of planned products to moderni…

Robert A. Garechana Appointed Chief Financial Officer

Robert A. Garechana Appointed Chief Financial Officer

Sun Communities, Inc., a REIT specializing in manufactured housing and RV communities, announced the appointment of Robert A. Garechana as Executive Vice President and Chief Financial Officer effective September 8, 2026. Garechana brings over 20 years of REIT finance experience, previously serving in top financial roles at Equity Residential. The c…

Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors

Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors

Parabilis Medicines announced the appointment of Dr. Craig L. Tendler, an accomplished oncology drug development leader formerly at Johnson & Johnson, to its Board of Directors. Dr. Tendler's extensive experience in clinical development, medical affairs, and successful oncology drug approvals will support Parabilis's ongoing clinical programs, incl…